US 10941143
Imidazo [1,5-a]pyridine compounds and their use
granted A61PA61P25/16A61P25/24
Quick answer
US patent 10941143 (Imidazo [1,5-a]pyridine compounds and their use) held by Alterity Therapeutics Limited expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alterity Therapeutics Limited
- Grant date
- Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P25/16, A61P25/24, A61P25/28